Pharmidex attends University of Sheffield’s Medical School Annual Research Meeting
July 15, 2017

The Medical School will hold its 13th Annual Research Meeting on 15th and 16th June 2017 in the Octagon Centre (poster presentations) and the Student Union Auditorium (oral presentations).

Pharmidex attends University of Sheffield’s Medical School Annual Research Meeting

Pharmidex will be attending the University of Sheffield's annual medical school research meeting. The Medical School will hold its 13th Annual Research Meeting on 15th and 16th June 2017 in the Octagon Centre (poster presentations) and the Student Union Auditorium (oral presentations).


The meeting will begin on Thursday 15th June 2017 with a programme of events organised by the Medicine, Dentistry and Health Research Staff Association & Medical Postgraduate Society (“Research Success: Having an impact”). We are pleased to announce the invited external speaker and judge will be Professor Gillian Bates from the UCL Institute of Neurology, London (Keynote Lecture Title: “Insights into the molecular basis of Huntington’s Disease”). Our internal judge will be Professor Nigel Clarke (Pro-Vice-Chancellor for the Faculty of Science).


On Friday 16th June 2017, there will be a programme of oral and poster presentations as well as invited speakers and a key-note lecture delivered by Professor Bates. Posters will be displayed throughout the the meeting (15th - 16th June 2017). 


https://www.sheffield.ac.uk/medicine/meeting/index


15th and 16th June 2017

June 11, 2025
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
June 10, 2025
Martin Barrett , Head of Business Development, will attend the symposium on 10–13 June 2025 at Hotel Comwell Borupgaard, Denmark. The event gathers top European scientists to discuss drug discovery. Martin looks forward to connecting with academia, CROs, and pharma to explore collaborations and showcase Pharmidex’s services from in silico to in vivo pharmacology. Attending? Let’s connect! 🔗 https://lnkd.in/ev7TW7WG
June 10, 2025
We’re excited to announce our involvement in the recent publication: "Anti-Inflammatory Activity of Ensifentrine: A Novel, Selective Dual Inhibitor of PDE3 and PDE4" 📄 https://pubmed.ncbi.nlm.nih.gov/40245851/ 📄 https://www.pharmidex.com/publications-by-pharmidex Dr. Radhakrishnan Venkatasamy , our Senior Scientist in autoinflammatory and immune diseases, co-authored this study highlighting Ensifentrine’s anti-inflammatory potential. This reflects Pharmidex’s commitment to advancing therapies through expert science and collaboration.
More Posts